Comparison and compilation of RA & QA requirements for marketing authorization of medical devices & diagnostics across selected regulated and emerging markets

By:

Language: English Publication details: 2018Edition: 1Description: 113pSubject(s):

DDC classification:

Dissertation note: Pramod Kumar T.MJSSAHERP.Regulatory Affairs

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Barcode
Dissertation/Thesis	JSS College of Pharmacy, Mysuru	JSS College of Pharmacy, Mysuru	Pharmaceutics	615.48 SUH (Browse shelf(Opens below))	Available	D10806

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.48 SRI Regulatory requirements for pharmaceutical product registration in Argentina	615.48 SRI Registration of generic injectables and ophthalmics in USA and ASEAN countries: comparative evaluation	615.48 SRI Opportunities and challenges in the implementation of ICHQ9 with emphasis to a WHO approved pharmaceutical plant	615.48 SUH Comparison and compilation of RA & QA requirements for marketing authorization of medical devices & diagnostics across selected regulated and emerging markets	615.48 SUJ Current trends of regulatory requirement in national market applicable to medico regulatory aspects in oral dosage and parenterals	615.48 SUJ Clinical trials on medical devices	615.48 SUM Comparison & compilation of RA & QA requirements for registration/marketing authorization of herbal & nutraceuticals across regulated & emerging markets	Next